News

13 Apr: Life sciences, business, and research leaders ask Prime Minister Trudeau for a new approach to the sector, so Canadians can get back to those ‘everyday moments’

Life Sciences Ontario has just launched a critical initiative to support the life sciences sector here in the province and at the national level. LSO has rallied life sciences, research and business leaders from across Canada to send an open letter to Prime Minister Trudeau, urging him to work with…

04 Mar: Canadians are paying the price for failed drug-pricing policy

Dr. Jason Field’s separates facts from fiction in a constructive www.healthydebate.ca article (https://healthydebate.ca/opinions/failed-drug-pricing-policy/). When other countries were working collaboratively with the life sciences sector as soon as #COVID hit, Health Canada was imposing drastic and uncertain price controls. Myths are separated from facts on key issues, including How much Canadians actually spend…

25 Nov: Life Science Ontario Announces Recipients of the 2021 LSO Awards

TORONTO–(BUSINESS WIRE)–LSO today announced the recipients of its 2021 LSO Awards, recognizing outstanding individuals and companies contributing to the success of Ontario’s life sciences sector. The awards will be presented during LSO’s Celebration of Success Awards in February 2021. The 2021 awardees are as follows: Lifetime Achievement Award: Michael Julius Community Service…

18 Nov: LSO Submission to the HESA study on PMPRB

Subject: HESA study on the reforms of the Patented Medicine Prices Review Board (PMPRB) Dear Honourable Members,Life Sciences Ontario (LSO) is a not-for-profit organization that represents and promotes Ontario’s vibrant and diverse life sciences sector. Members of LSO include life sciences companies, entrepreneurs, members of academia, and service providers from…

13 Aug: LSO RESPONDS TO THE PMPRB’S JUNE 2020 DRAFT GUIDELINES CONSULTATION

Life Sciences Ontario remains deeply concerned about the federal government’s patented medicine price controls and their potential to undermine the life sciences sector’s efforts to support the health and well-being of Canadians and the economy, particularly during the unprecedented COVID-19 pandemic. There is a growing body of evidence showing that…

02 Jun: LSO supports delay of federal drug pricing rules implementation

Life Sciences Ontario applauds the federal government’s recent decision to delay the implementation of the Patented Medicines Regulations to January 1, 2021 as part of the response to the COVID-19 crisis. This measure will help the Canadian life sciences sector remain unwaveringly focused on developing vaccines, treatments, and other tools to fight…

19 Mar: How LSO Members are combating the spread of COVID-19

LSO put out a call to our members requesting insights on how companies are working together to combat the rapid spread of the novel COVID-19 virus. Below are some examples of how we, as a community are helping to control the outbreak. Member Announcements Amgen Canada: Amgen will provide its…